BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 1740491)

  • 1. Evidence for a critical role of progesterone in the regulation of the midcycle gonadotropin surge and ovulation.
    Batista MC; Cartledge TP; Zellmer AW; Nieman LK; Merriam GR; Loriaux DL
    J Clin Endocrinol Metab; 1992 Mar; 74(3):565-70. PubMed ID: 1740491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blockade of the spontaneous midcycle gonadotropin surge in monkeys by RU 486: a progesterone antagonist or agonist?
    Collins RL; Hodgen GD
    J Clin Endocrinol Metab; 1986 Dec; 63(6):1270-6. PubMed ID: 3097053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disruption of follicular maturation and delay of ovulation after administration of the antiprogesterone RU486.
    Liu JH; Garzo G; Morris S; Stuenkel C; Ulmann A; Yen SS
    J Clin Endocrinol Metab; 1987 Dec; 65(6):1135-40. PubMed ID: 2824550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute effects of progesterone and the antiprogestin RU 486 on gonadotropin secretion in the follicular phase of the menstrual cycle.
    Permezel JM; Lenton EA; Roberts I; Cooke ID
    J Clin Endocrinol Metab; 1989 May; 68(5):960-5. PubMed ID: 2497130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of folliculogenesis and ovulation by the antiprogesterone RU 486.
    Luukkainen T; Heikinheimo O; Haukkamaa M; Lähteenmäki P
    Fertil Steril; 1988 Jun; 49(6):961-3. PubMed ID: 3371492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Midcycle levels of sex steroids are sufficient to recreate the follicle-stimulating hormone but not the luteinizing hormone midcycle surge: evidence for the contribution of other ovarian factors to the surge in normal women.
    Taylor AE; Whitney H; Hall JE; Martin K; Crowley WF
    J Clin Endocrinol Metab; 1995 May; 80(5):1541-7. PubMed ID: 7744998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant human inhibin-A administered early in the menstrual cycle alters concurrent pituitary and follicular, plus subsequent luteal, function in rhesus monkeys.
    Molskness TA; Woodruff TK; Hess DL; Dahl KD; Stouffer RL
    J Clin Endocrinol Metab; 1996 Nov; 81(11):4002-6. PubMed ID: 8923851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of endogenous opioid peptides in the initiation of the midcycle luteinizing hormone surge in normal cycling women.
    Rossmanith WG; Mortola JF; Yen SS
    J Clin Endocrinol Metab; 1988 Oct; 67(4):695-700. PubMed ID: 3138276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the antiprogesterone RU 486 in normal women. II. Administration in the late follicular phase.
    Shoupe D; Mishell DR; Page MA; Madkour H; Spitz IM; Lobo RA
    Am J Obstet Gynecol; 1987 Dec; 157(6):1421-6. PubMed ID: 2827482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of daily low dose mifepristone on the ovarian cycle and on dynamics of follicle growth.
    Cameron ST; Thong KJ; Baird DT
    Clin Endocrinol (Oxf); 1995 Oct; 43(4):407-14. PubMed ID: 7586613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of folliculogenesis in the cycling rhesus monkey: selection of the dominant follicle.
    Goodman AL; Nixon WE; Johnson DK; Hodgen GD
    Endocrinology; 1977 Jan; 100(1):155-61. PubMed ID: 401483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of pre-ovulatory progesterone in the midcycle gonadotrophin surge, ovulation and subsequent luteal phase: studies with RU486 in rhesus monkeys.
    Remohi J; Balmaceda JP; Rojas FJ; Asch RH
    Hum Reprod; 1988 May; 3(4):431-5. PubMed ID: 3134390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of low dose hCG for luteal support after triggering ovulation with a GnRH agonist in cases of polyfollicular development.
    Krause BT; Ohlinger R
    Eur J Obstet Gynecol Reprod Biol; 2006 May; 126(1):87-92. PubMed ID: 16377065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variable effects of RU 486 on endometrial maintenance in the luteal phase extended by exogenous hCG.
    Croxatto HB; Salvatierra AM; Croxatto HD; Spitz IM
    Clin Endocrinol (Oxf); 1989 Jul; 31(1):15-23. PubMed ID: 2598478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The antiprogestin RU486 delays the midcycle gonadotropin surge and ovulation in gonadotropin-releasing hormone-induced cycles.
    Batista MC; Cartledge TP; Zellmer AW; Nieman LK; Loriaux DL; Merriam GR
    Fertil Steril; 1994 Jul; 62(1):28-34. PubMed ID: 8005300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Initiation of periovulatory events in primate follicles using recombinant and native human luteinizing hormone to mimic the midcycle gonadotropin surge.
    Chandrasekher YA; Hutchison JS; Zelinski-Wooten MB; Hess DL; Wolf DP; Stouffer RL
    J Clin Endocrinol Metab; 1994 Jul; 79(1):298-306. PubMed ID: 8027245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Follicular stimulation versus ovulation induction in juvenile primates: importance of gonadotropin-releasing hormone dose.
    Sopelak VM; Collins RL; Hodgen GD
    J Clin Endocrinol Metab; 1986 Mar; 62(3):557-62. PubMed ID: 3080466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of an antiprogesterone (RU486) on the hypothalamic-hypophyseal-ovarian-endometrial axis during the luteal phase of the menstrual cycle.
    Garzo VG; Liu J; Ulmann A; Baulieu E; Yen SS
    J Clin Endocrinol Metab; 1988 Mar; 66(3):508-17. PubMed ID: 2832438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of the antiprogesterone steroid RU 486 during midluteal phase in normal women.
    Schaison G; George M; Lestrat N; Reinberg A; Baulieu EE
    J Clin Endocrinol Metab; 1985 Sep; 61(3):484-9. PubMed ID: 2991322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progesterone effects on gonadotropin release in women pretreated with estradiol.
    Chang RJ; Jaffe RB
    J Clin Endocrinol Metab; 1978 Jul; 47(1):119-25. PubMed ID: 122395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.